How reliable is the CA125?

23rd July 2021

While the CA125 blood test is useful for diagnosing and monitoring people with ovarian cancer, 25% of ​patients with ovarian cancers will have a normal CA125 level. Therefore, the CA125 test alone is not an accurate diagnostic tool ​and primary care professionals should consider requesting an ultrasound scan if clinical concern persists despite a normal CA125.

To learn more, access GatewayC’s ‘Ovarian Cancer – Early Diagnosis’ course. This course aims to support healthcare professionals to recognise symptoms, understand genetic risk factors and comprehend essential investigations.

Find out more:

  • Access GatewayC’s ‘Ovarian Cancer – Early Diagnosis’ course here
  • Watch GatewayC Live’s webinar recording on Diagnosing Ovarian Cancer here
  • Read Ovarian Cancer Action’s guide for primary care here
  • Read GatewayC’s ‘Tips to elicit your patient’s family history of BRCA1 and BRCA2’ blog here

LinkedIn | Twitter | Facebook

Latest from the Blog

Health anxiety and fear of recurrence

Health anxiety and fear of recurrence

21st May 2020 Managing a patient’s fear of cancer recurrence and health anxiety can be difficult. After treatment, many patients want to have the reassurance that they are cured. Generally it is not possible for health care professionals to say with absolute certainty...

read more
Safety netting in primary care

Safety netting in primary care

13th May 2020 In times of uncertainty safety netting is an important part of the primary care consultation and referral process. When followed correctly, safety netting can help ensure patients are monitored appropriately and follow-ups take place where required. This...

read more

Related Posts

Preparing a patient for a suspected cancer referral

Preparing a patient for a suspected cancer referral

2nd April 2019 Up to 1 in 10 patients do not attend their two week wait appointment, with some patients not understanding the seriousness of the referral. This statistic shows how important it is for GPs to share their concerns around the possibility of cancer, but...

read more